INTRAOSSEOUS INFUSI

The contract specifies the procurement of an intraosseous infusion system, a manual, sterile, latex-free device featuring seven-site access, equipped with a 15-gauge 304 stainless steel needle/catheter, a sharps protector, an EZ connector extension set, and an I/O wristband. Each unit must meet strict medical marking standards, be labeled with the manufacturer date, expiration or retest date, and contract or lot number, and maintain a 48-month shelf life, with no more than seven months elapsed between manufacture and government delivery. The item is identified by NSN 6515-01-626-6395 and is to be delivered in a quantity of 26 units within 20 days of award. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with compliance based on the revision in effect at the solicitation or award date. Packaging must adhere to DLA standards, and non-accepted supplies must have all government identification removed. Bidders are required to provide the source and part number being offered. The solicitation, issued under SPE2DS-26-T-048N, is managed by the Department of Defense’s Medical Supply Chain, with performance required at Fort Bragg, North Carolina, and proposals due by May 11, 2026.